(Q20801763)

parenteral route of administration

17 November 2015

0.2 milligram

route of administration

1 reference

reference URL

https://www.whocc.no/atc_ddd_index/?code=L03AC01

medical condition treated

1 reference

human immunodeficiency virus infectious disease

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

Bellini duct carcinoma

1 reference

13 December 2016

large intestine cancer

1 reference

13 December 2016

1 reference

https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802

13 December 2016

legal status (medicine)

boxed warning

1 reference

reference URL

FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (English)

has characteristic

biopharmaceutical

1 reference

Aldesleukin (English)

stated in

DrugBank

17 November 2015

1 reference

5 March 2018

1 reference

5 March 2018

1 reference

Medical Subject Headings

15 March 2018

1 reference

Medical Subject Headings

MeSH descriptor ID

C082598

15 March 2018

Identifiers

1 reference

Aldesleukin (English)

17 November 2015

0 references

1 reference

Guide to Pharmacology Ligand ID

Aldesleukin (English)

publication date

17 November 2015

0 references

1 reference

Medical Subject Headings

14 March 2018

1 reference

26 February 2018

0 references

1 reference

ALDESLEUKIN (English)

MedlinePlus drug identifier

19 January 2016

a692009

0 references

PatientsLikeMe treatment ID

0 references

1 reference

ALDESLEUKIN (English)